In vitro and in vivo inhibitory activity of the differentiation-inducing agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) against rat choriocarcinoma

Advances in Experimental Medicine and Biology

Volumn 431, Issue , 1998, Pages 605-609

  Hatse, S ^a   Naesens, L ^a   Degreve B ^a   Vandeputte, M ^a   Waer, M ^b   De Clercq, E ^a   Balzarini, J ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ADENINE DERIVATIVE; ALKALINE PHOSPHATASE; METHOTREXATE; PROGESTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CELL DIFFERENTIATION; CHORIOCARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME INDUCTION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; PROGESTERONE RELEASE; RAT;

ANIMALIA;

EID: 0031836757     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5381-6_117     Document Type: Conference Paper

References (16)

1. De Clercq, E., Holy, A., Rosenberg, I. Sakuma, T., Balzarini, J., and Maudgal, P.C. Nature 323: 464-467 (1986).
2. De Clercq, E., Sakuma, T., Baba, M., Pauwels, R., Balzarini, J., Rosenberg, I. and Holy, A. Antiviral Res. 8:261-272 (1987).
3. Heijtink, R.A., De Wilde, G.A., Kruining, J., Berk, L., Balzarini, J., De Clercq, E., Holy, A., and Schalm, S.W. Antiviral Res. 21: 141-153 (1993).
4. Balzarini, J., Naesens, L., Herdewijn, R, Rosenberg, I., Holy, A., Pauwels, R., Baba, M., Johns, D.G. and De Clercq, E. Proc. Natl. Acad. Sci. USA, 86: 332-336 (1989).
5. Balzarini, J., Naesens, L., and De Clercq, E. Int. J. Cancer 46: 337-340 (1990).
6. Balzarini, J., Verstuyf, A., Hatse, S., Goebels, J., Sobis, H., Vandeputte, M., and De Clercq, E. Int. J. Cancer 61: 130-137 (1995).
7. Verstuyf, A., Sobis, H., Goebels, J., Fonteyn, E., Cassiman, J.J., and Vandeputte, M. Int. J. Cancer 45: 752-756 (1990).
8. Verstuyf, A., Sobis, H., and Vandeputte, M. Int. J. Cancer 44: 879-884 ( 1989).
9. Friedman, S.J., and Skehan, P. Cancer Res. 39: 1960-1967 (1979).
10. Botte, V., Tramontana, S., and Chieffi, G. J. Endocrinol. 40: 189-194 (1968).
11. Campbell, W.J., Larsen, D., Deb, S., Kwok, S.C.M., and Soares, M.J. Placenta 12: 227-237 (1991).
12. Holy, A., and Rosenberg, I. Collect. Czech. Chem. Commun. 52: 2801-2809 (1987).
13. Balzarini, J., Hao, Z., Herdewijn, P., Johns, D.G., and De Clercq, E. Proc. Natl. Acad. Sci. USA 88: 1499-1503 (1991).
14. Balzarini, J., Holy, A., Jindrich, J., Naesens, L., Snoeck, R., Schols, D. and De Clercq, E. Antimicrob. Agents Chemother. 37: 332-338 (1993).
15. Verstuyf, A., Goebels, J., Sobis, H., and Vandeputte, M. Tumor Biol. 14: 46-54 (1993).
16. Pommier, Y., and Lokiec, F. Chimiothérapie anticancereuse 31: 3083-3089 (1981).